Long-term efficacy and safety of baxdrostat in patients with uncontrolled or resistant hypertension: results from the BaxHTN phase 3 trial
30 August 2026 (14:30 - 14:45)
Organised by: 
Slides
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Professor H. Heerspink (Groningen, NL)
Associate Professor L. Laffin (Cleveland, US)
Access the full session
The Event
ESC Congress 2026
30 August 2026
14:30 CET
You may be interested in
Congress Presentation
Webinar
Webinar
10 July 2023
Congress Presentation
